Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,760
datasets available to search
ShareScore release 0.9.0
Dataset results
1,760 results for “phase 2”
A Phase 2 Study to Evaluate the Safety and Efficacy of TAK-385, Together With a Leuprorelin Observational Cohort, in Participants With Prostate Cancer
ClinicalTrials.gov study NCT02083185. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Phase 2 Study of Glesatinib, Sitravatinib or Mocetinostat in Combination With Nivolumab in Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT02954991. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase 2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat
ClinicalTrials.gov study NCT00618618. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Phase 2, Randomized, Double Blind, Placebo Controlled Multicenter Study of Autologous MSC-NTF Cells in Patients With ALS
ClinicalTrials.gov study NCT02017912. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 2 Study of Zevalin Versus Zevalin and Motexafin Gadolinium in Patients With Rituximab-Refractory Low-grade or Follicular B-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT01549886. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Single Centre, Phase I, Double-blind, Randomised, Placebo-controlled Study to Investigate the Safety, Tolerability, Pharmacokinetic Profile and Effects on EEG of Single Rising Oral Doses of BIA 2-09
ClinicalTrials.gov study NCT02171195. IPD Sharing: Not stated. Countries: 1. Publications: 0.
EMPIRE CF: A Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of CTX-4430 in Adult Cystic Fibrosis (CF) Patients
ClinicalTrials.gov study NCT02443688. IPD Sharing: Not stated. Countries: 7. Publications: 0.
A Phase 4, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 4, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT02324569. IPD Sharing: YES. Countries: 1. Publications: 0.
Phase 2 Chronic Low Back Pain Study
ClinicalTrials.gov study NCT01364922. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Program ACTIVE: Phase 2
ClinicalTrials.gov study NCT04369001. IPD Sharing: UNDECIDED. Countries: 0. Publications: 32.
A Phase 2, Open-label Study of AMG 706 to Treat Subjects With Locally Advanced or Metastatic Thyroid Cancer
ClinicalTrials.gov study NCT00121628. IPD Sharing: Not stated. Countries: 0. Publications: 2.
BRAZAN: A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve
ClinicalTrials.gov study NCT06854003. IPD Sharing: YES. Countries: 1. Publications: 0.
A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic Influenza
ClinicalTrials.gov study NCT05648448. IPD Sharing: YES. Countries: 4. Publications: 0.
A Phase 2 Safety and Immunogenicity Study for an Anthrax Vaccine Using 3 Schedules and Two Dose Levels
ClinicalTrials.gov study NCT01770743. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 2 Study to Assess the Safety and Efficacy of IMO-2125 With 8 mg Ipilimumab in Patients With Metastatic Melanoma
ClinicalTrials.gov study NCT02644967. IPD Sharing: NO. Countries: 1. Publications: 0.
Open-label Extension to the Phase 2 Crossover Study (PRESIDIO) Evaluating KZR-616 in Patients With PM and DM.
ClinicalTrials.gov study NCT04628936. IPD Sharing: NO. Countries: 2. Publications: 0.
Phase 2 Trial of TD 6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)
ClinicalTrials.gov study NCT00061633. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 2 Hypofractionation Study Using Proton Beam Therapy for Prostate Adenocarcinoma
ClinicalTrials.gov study NCT01709253. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase 2 Trial of TD-6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)
ClinicalTrials.gov study NCT00077675. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy
ClinicalTrials.gov study NCT01200394. IPD Sharing: YES. Countries: 15. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.